SCHEMBL2848967

SCHEMBL2848967

[CH2]CC(N)CCCCCCCCCCCC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 1/20 0.54
PLA2G2A P14555 1/20 0.54
OPRM1 P35372 1/20 0.50
S1PR2 O95136 5/20 0.48
S1PR1 P21453 5/20 0.48
S1PR3 Q99500 5/20 0.48
S1PR4 O95977 4/20 0.48
SPHK1 Q9NYA1 2/20 0.46
CYP2D6 P10635 2/20 0.43
LMNA P02545 2/20 0.43
GMNN O75496 1/20 0.43
POLB P06746 1/20 0.43
THPO P40225 1/20 0.43
MTOR P42345 1/20 0.43
BLM P54132 1/20 0.43
KDM4E B2RXH2 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27676253 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL27398850 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL27555692 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL28148302 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL16910640 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL7568974 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL11792633 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL10318625 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL20680492 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1
SCHEMBL27694844 1.00 PLA2G1B (0.54) PLA2G1BPLA2G2AOPRM1S1PR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108342387-A The delivery system and biological agent of PCSK9 inhibitor class hypolipidemics 谭旭 2018-07-31 CN claimed
CN-106729753-A The delivery system and biological agent of anti-hepatitis B virus 谭旭 2017-05-31 CN claimed
CN-116322328-A Pesticide composition comprising elemental sulphur and choline salts of pelargonic acid 希特逊库玛·阿尼凯特·多希 2023-06-23 CN disclosed
CN-116193988-A Pesticide composition containing elemental sulfur and flurofuranone 希特逊库玛·阿尼凯特·多希 2023-05-30 CN disclosed
CN-108342387-A The delivery system and biological agent of PCSK9 inhibitor class hypolipidemics 谭旭 2018-07-31 CN disclosed
CN-106999417-A Personal cleansing compositions and methods 宝洁公司 2017-08-01 CN disclosed
CN-106729753-A The delivery system and biological agent of anti-hepatitis B virus 谭旭 2017-05-31 CN disclosed
CN-104119438-A Human anti-iL-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases MEDIMMUNE LLC 2014-10-29 CN disclosed
US-8633136-B2 Agricultural adjuvant compositions, pesticide compositions, and methods for using such compositions RHODIA OPERATIONS (FR) 2014-01-21 US disclosed
US-8354128-B2 Blackberry leaf extract as an active ingredient against skin irritations and inflammations SYMRISE AG (DE) 2013-01-15 US disclosed
CN-1966090-B Deodorant compositions KAO CORP 2012-09-05 CN disclosed
US-20120165195-A1 Agricultural Adjuvant Compositions, Pesticide Compositions, and Methods for Using Such Compositions RHODIA INC. (US) 2012-06-28 US disclosed
CN-102387814-A Human anti-IL-6 antibodies with extended in vivo half-life and their use in treating tumors, autoimmune and inflammatory diseases MEDIMMUNE LLC 2012-03-21 CN disclosed
US-20100239695-A1 BLACKBERRY LEAF EXTRACT AS AN ACTIVE INGREDIENT AGAINST SKIN IRRITATIONS AND INFLAMMATIONS SYMRISE GMBH & CO. KG (DE) 2010-09-23 US disclosed
US-20100029483-A1 AGRICULTURAL ADJUVANT COMPOSITIONS, PESTICIDE COMPOSITIONS, AND METHODS FOR USING SUCH COMPOSITIONS RHODIA INC. (US) 2010-02-04 US disclosed
WO-2008066611-A2 AGRICULTURAL ADJUVANT COMPOSITIONS. PESTICIDE COMPOSITIONS. AND METHODS FOR USING SUCH COMPOSITIONS RHODIA INC. (US) 2008-06-05 WO disclosed
CN-1966090-A Deodorant compositions KAO CORP (JP) 2007-05-23 CN disclosed
EP-1042007-B1 AMINOBIGUANIDES AND THE USE THEREOF TO DISINFECT CONTACT LENSES AND PRESERVE PHARMACEUTICAL COMPOSITIONS ALCON LAB INC (US) 2004-08-11 EP disclosed
US-4181624-A MIXTURES FROM NONTERMINAL EPOXYALKANES, AMMONIA, AND WATER HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 1980-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029483-A1 AGRICULTURAL ADJUVANT COMPOSITIONS, PESTICIDE COMPOSITIONS, AND METHODS FOR USING SUCH COMPOSITIONS PHOSPHO1, INPP5D, AGPS PLA2G1B 58/4885PLA2G2A 142/4885OPRM1 3162/4885
US-20120165195-A1 Agricultural Adjuvant Compositions, Pesticide Compositions, and Methods for Using Such Compositions PHOSPHO1, INPP5D, AGPS PLA2G1B 55/4885PLA2G2A 150/4885OPRM1 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.